Publications for the metabolite Theophylline with food phytochemical Caffeine

1. Bracco D, Ferrarra JM, Arnaud MJ, Jequier E, Schutz Y: Effects of caffeine on energy metabolism, heart rate, and methylxanthine metabolism in lean and obese women. Am J Physiol. 1995 Oct;269(4 Pt 1):E671-8. doi: 10.1152/ajpendo.1995.269.4.E671. [PubMed:7485480 ]
2. Bano G, Raina RK, Zutshi U, Bedi KL, Johri RK, Sharma SC: Effect of piperine on bioavailability and pharmacokinetics of propranolol and theophylline in healthy volunteers. Eur J Clin Pharmacol. 1991;41(6):615-7. doi: 10.1007/BF00314996. [PubMed:1815977 ]
3. Grygiel JJ, Birkett DJ: Cigarette smoking and theophylline clearance and metabolism. Clin Pharmacol Ther. 1981 Oct;30(4):491-6. doi: 10.1038/clpt.1981.193. [PubMed:7285483 ]
4. Fox RW, Samaan S, Bukantz SC, Lockey RF: Theophylline kinetics in a geriatric group. Clin Pharmacol Ther. 1983 Jul;34(1):60-7. doi: 10.1038/clpt.1983.130. [PubMed:6861439 ]
5. Harrison LI, Kehe CR, Ekholm BP, Chang SF, Lavoie KA, Kisicki JC: Comparative pharmacokinetics of morning and evening doses of once-a-day theophylline capsules. J Pharm Sci. 1994 Aug;83(8):1171-4. doi: 10.1002/jps.2600830818. [PubMed:7983603 ]
6. Fourtillan JB, Granier J, Saint-Salvi B, Salmon J, Surjus A, Tremblay D, Vincent Du Laurier M, Beck S: Pharmacokinetics of ofloxacin and theophylline alone and in combination. Infection. 1986;14 Suppl 1:S67-9. doi: 10.1007/BF01645203. [PubMed:3456985 ]
7. Dadashzadeh S, Tajerzaden H: Dose dependent pharmacokinetics of theophylline: Michaelis-Menten parameters for its major metabolic pathways. Eur J Drug Metab Pharmacokinet. 2001 Jan-Jun;26(1-2):77-83. doi: 10.1007/BF03190380. [PubMed:11554438 ]
8. Jonkman JH, van der Boon WJ, Balant LP, Le Cotonnec JY: Food reduces the rate but not the extent of the absorption of theophylline from an aqueous solution. Eur J Clin Pharmacol. 1985;28(2):225-7. doi: 10.1007/BF00609697. [PubMed:3987803 ]
9. Varshosaz J, Ghafghazi T, Raisi A, Falamarzian M: Biopharmaceutical characterization of oral theophylline and aminophylline tablets. Quantitative correlation between dissolution and bioavailability studies. Eur J Pharm Biopharm. 2000 Sep;50(2):301-6. doi: 10.1016/s0939-6411(00)00074-6. [PubMed:10962242 ]
10. Schlaeffer F, Engelberg I, Kaplanski J, Danon A: Effect of exercise and environmental heat on theophylline kinetics. Respiration. 1984;45(4):438-42. doi: 10.1159/000194651. [PubMed:6473926 ]
11. Hotchkiss SA, Caldwell J: High-performance liquid chromatographic assay for theophylline and its major metabolites in human urine. J Chromatogr. 1987 Dec 25;423:179-88. doi: 10.1016/0378-4347(87)80341-9. [PubMed:3443648 ]
12. Peh KK, Yuen KH: In Vivo Bioavailability of a Multiparticulate Matrix Sustained-Release Theophylline Preparation Under Fed and Fasted Conditions Drug Development and Industrial Pharmacy. 1997;23(1):15-18.
13. Tajerzadeh H, Dadashzadeh S: An isocratic high-performance liquid chromatographic system for simultaneous determination of theophylline and its major metabolites in human urine Journal of Pharmaceutical and Biomedical Analysis. 16 December 1999;13(12):1507-1512.
14. Wang L, Hu Z, Deng X, Wang Y, Zhang Z, Cheng ZN: Association between common CYP1A2 polymorphisms and theophylline metabolism in non-smoking healthy volunteers. Basic Clin Pharmacol Toxicol. 2013 Apr;112(4):257-63. doi: 10.1111/bcpt.12038. Epub 2012 Dec 20. [PubMed:23167834 ]
15. Kamali F, Edwards C, Rawlins MD: Lack of effect of flosequinan on the pharmacokinetics of theophylline. Br J Clin Pharmacol. 1991 Jul;32(1):124-6. doi: 10.1111/j.1365-2125.1991.tb05624.x. [PubMed:1888632 ]
16. Lelo A, Birkett DJ, Robson RA, Miners JO: Comparative pharmacokinetics of caffeine and its primary demethylated metabolites paraxanthine, theobromine and theophylline in man. Br J Clin Pharmacol. 1986 Aug;22(2):177-82. doi: 10.1111/j.1365-2125.1986.tb05246.x. [PubMed:3756065 ]
17. Gai MN, Thielemann AM, Arancibia A: Evaluation of the effect of different kinds of foods on the bioavailability of a sustained-release theophylline tablet. Int J Clin Pharmacol Ther Toxicol. 1993 Nov;31(11):547-52. [PubMed:8294167 ]
18. Couet W, Ingrand I, Reigner B, Girault J, Bizouard J, Fourtillan JB: Lack of effect of ponsinomycin on the plasma pharmacokinetics of theophylline. Eur J Clin Pharmacol. 1989;37(1):101-4. doi: 10.1007/BF00609435. [PubMed:2591458 ]
19. Ohashi K, Sakamoto K, Sudo T, Tateishi T, Fujimura A, Shiga T, Ebihara A: Effects of diltiazem and cimetidine on theophylline oxidative metabolism. J Clin Pharmacol. 1993 Dec;33(12):1233-7. doi: 10.1002/j.1552-4604.1993.tb03925.x. [PubMed:8126258 ]
20. Apseloff G, Shepard DR, Chambers MA, Nawoot S, Mays DC, Gerber N: Inhibition and induction of theophylline metabolism by 8-methoxypsoralen. In vivo study in rats and humans. Drug Metab Dispos. 1990 May-Jun;18(3):298-303. [PubMed:1974189 ]
21. Gardner MJ, Tornatore KM, Jusko WJ, Kanarkowski R: Effects of tobacco smoking and oral contraceptive use on theophylline disposition. Br J Clin Pharmacol. 1983 Sep;16(3):271-80. doi: 10.1111/j.1365-2125.1983.tb02161.x. [PubMed:6626419 ]
22. Blanchard J, Sawers SJ, Jonkman JH, Tang-Liu DD: Comparison of the urinary metabolite profile of caffeine in young and elderly males. Br J Clin Pharmacol. 1985 Feb;19(2):225-32. doi: 10.1111/j.1365-2125.1985.tb02635.x. [PubMed:3986081 ]
23. Carrillo JA, Benitez J: Caffeine metabolism in a healthy Spanish population: N-acetylator phenotype and oxidation pathways. Clin Pharmacol Ther. 1994 Mar;55(3):293-304. doi: 10.1038/clpt.1994.30. [PubMed:8143395 ]
24. Cysneiros RM, Farkas D, Harmatz JS, von Moltke LL, Greenblatt DJ: Pharmacokinetic and pharmacodynamic interactions between zolpidem and caffeine. Clin Pharmacol Ther. 2007 Jul;82(1):54-62. doi: 10.1038/sj.clpt.6100211. Epub 2007 Apr 18. [PubMed:17443132 ]
25. Jeppesen U, Loft S, Poulsen HE, Brsen K: A fluvoxamine-caffeine interaction study. Pharmacogenetics. 1996 Jun;6(3):213-22. doi: 10.1097/00008571-199606000-00003. [PubMed:8807660 ]
26. Grant DM, Tang BK, Kalow W: Variability in caffeine metabolism. Clin Pharmacol Ther. 1983 May;33(5):591-602. doi: 10.1038/clpt.1983.80. [PubMed:6687705 ]
27. Kaplan GB, Greenblatt DJ, Ehrenberg BL, Goddard JE, Cotreau MM, Harmatz JS, Shader RI: Dose-dependent pharmacokinetics and psychomotor effects of caffeine in humans. J Clin Pharmacol. 1997 Aug;37(8):693-703. doi: 10.1002/j.1552-4604.1997.tb04356.x. [PubMed:9378841 ]
28. Rodopoulos N, Norman A: Assessment of dimethylxanthine formation from caffeine in healthy adults: comparison between plasma and saliva concentrations and urinary excretion of metabolites. Scand J Clin Lab Invest. 1996 May;56(3):259-68. doi: 10.3109/00365519609088615. [PubMed:8761530 ]